Tennessee's Failed Execution of Christa Pike: What Went Wrong and What Comes Next

Tennessee's attempt to execute convicted murderer Christa Pike by lethal injection has ended in failure, leaving the 50-year-old inmate hospitalized and under what her legal team describes as "life-saving measures." The extraordinary turn of events has ignited fresh debate about capital punishment in the United States, raised troubling questions about the state's execution protocols, and prompted a formal review ordered by Governor Bill Lee.

Pike had been scheduled to die on Wednesday evening local time for the 1996 torture and murder of 19-year-old Colleen Slemmer. The killing was carried out alongside Pike's then-boyfriend, Tadaryl Shipp. Pike, who was sentenced to death in 1996, had exhausted a lengthy series of legal appeals, and her execution was ultimately cleared by the US Supreme Court at the eleventh hour after a high-profile legal battle.

According to details emerging from the case, Pike received two syringes of the drug pentobarbital during the procedure. However, her legal team says the doses failed to stop her heartbeat, and she could still be heard snoring after the injections were administered. Rather than proceeding to death, Pike was transported to an off-site medical facility, where her lawyers say she is receiving emergency care. Her exact health status remained unclear as of Thursday morning.

The Tennessee Department of Correction has defended the method it used, stating that "the protocol does not allow for additional procedures beyond what was carried out this evening." That position has drawn scrutiny, particularly because the state's protocols do not clearly specify what should happen if an inmate remains alive after a second dose. The department has not explained why the dosage proved non-fatal, though it has denied allegations from Pike's legal team that the pentobarbital used was "degraded." In a broader statement, the department insisted that "the lethal injection chemical in the protocol has consistently been effective."

Medical experts have offered their own theories. Dr Joel Zivot, a professor at Emory University School of Medicine who told the BBC he was retained by Pike's legal team as a medical expert, suggested she likely never reached a sufficient blood concentration of pentobarbital to trigger apnoea and cardiovascular failure. He also warned that the delay in beginning resuscitation could leave Pike with a brain injury. "It's very possible that as a consequence of the delay of the beginning of resuscitation she will have a brain injury," Zivot said in emailed comments.

Governor Bill Lee has ordered a third-party review of the failed execution and announced that the state's last remaining scheduled execution of the year will not proceed as planned. The decision signals growing concern within the state about the reliability of its capital punishment procedures.

For Colleen Slemmer's family, the outcome has been painful. May Martinez, Slemmer's mother, who had pushed for Pike's execution to be carried out, told NBC News the events amounted to "a mess." She had waited nearly three decades for the sentence to be enforced, only to see the process collapse in a manner that has left Pike alive but potentially severely harmed.

Opponents of the death penalty reacted swiftly. Maya Foa, chief executive of the international legal organization Reprieve, criticized the secrecy surrounding lethal injection, saying: "We cannot know exactly what went wrong, because so much happened behind a curtain – lethal injection relies on secrecy at every stage, to hide the violence of the state taking a human life." Her comments reflect a longstanding argument that execution protocols shield authorities from accountability when procedures fail.

A central question now is whether Tennessee will attempt to execute Pike a second time. Authorities have not indicated their intentions, though there is historical precedent for states making repeated attempts to carry out a death sentence when an initial effort fails. That prospect raises complex legal and ethical issues, particularly given the uncertainty about Pike's current medical condition.

Shipp, Pike's co-defendant and boyfriend at the time of the murder, remains in prison but was spared the death penalty because he was 17 when Slemmer was killed, making him a juvenile under state law at the time. The disparity in sentencing has long been a point of contention in the case.

The drug at the center of the failed execution, pentobarbital, is a potent sedative that slows the body's systems, including the nervous system. While doctors sometimes use it to treat certain conditions, high doses can be lethal. Its use in executions came under renewed scrutiny last year after a federal review conducted during Joe Biden's presidency raised concerns about the drug's potential for "unnecessary pain and suffering." The federal government subsequently banned its use in federal executions, but that prohibition does not bind individual states like Tennessee, which set their own execution methods.

States have in recent years struggled to obtain the drugs required for lethal injections, as pharmaceutical companies have increasingly opposed the use of their products for capital punishment. This scarcity has complicated execution protocols across the country and, critics argue, contributed to botched procedures.

Pike's case is not the first problematic execution attempt in Tennessee in 2026. In May, the execution of Tony Carruthers, convicted of kidnapping and murdering three people in 1994, was postponed after staff could not locate a suitable vein to administer the lethal injection. Governor Lee granted him a one-year reprieve. Nationally, the issue of botched executions remains a serious concern: according to the Death Penalty Information Center, more than a third of US executions in 2022 were botched or highly problematic. The organization provides statistics and research on capital punishment but does not take a formal stance on its morality.

As Pike remains hospitalized and the state awaits the outcome of its review, the case has become a focal point for broader debates about the death penalty's reliability, transparency, and human cost. Questions persist about what exactly transpired in the execution chamber, whether the state will try again, and what lasting consequences Pike may face from an execution that was meant to end her life but instead left her in critical condition.